Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein R pseudogene 2 (HNRNPRP2)

Target
HNRNPRP2
Molecular classification
Other (Pseudogene)
01

Overview

HNRNPRP2 is a processed pseudogene, meaning it is a nonfunctional genomic element derived from a reverse-transcribed mRNA of an ancestral heterogeneous nuclear ribonucleoprotein R (HNRNPR) gene[1][5]. Pseudogenes commonly lack the regulatory sequences required for transcription or have mutations that prevent production of functional protein[5]. As a result, HNRNPRP2 does not produce an active protein and has no known biological function, disease association, or relevance as a drug target. The gene’s sequence overlaps with the hnRNP family, whose functional members are RNA-binding proteins involved in mRNA metabolism, but HNRNPRP2 itself is not functionally active[2][1][3]. Key Notes: - There is nothing to suggest HNRNPRP2 encodes a therapeutic target or is involved in any disease mechanism; it is a disabled, non-protein-coding genomic sequence[1][5]. - Functional hnRNP R or related proteins (like hnRNP A/B, hnRNP K) should not be confused with pseudogenes such as HNRNPRP2, which are relics without transcriptional or translational activity[2][5]. - As per standardized genomics nomenclature, pseudogenes like HNRNPRP2 are not biomedically actionable, and querying them as potential drug targets or biomarkers is incorrect[1][5]. If your interest is in the functional hnRNP R protein, this is a distinct and separate gene (not the pseudogene), which is an RNA-binding protein involved in mRNA metabolism[2].

Other names
HNRNPRP2

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein R pseudogene 2 (HNRNPRP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein R pseudogene 2 (HNRNPRP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call